Skip to content

NAMSNEWAMSTERDAM PHARMA CO NV

CUSIP N62509109 · common stock

5 tracked investors held NEWAMSTERDAM PHARMA CO NV (NAMS) at the end of Q3 2026, worth $421.8M in total. The largest holder was RA Capital Management, with 2.3% of its portfolio. Ron Baron sold out of its position this quarter.

Holders · Q3 2026
5
New holders
0
Value held
$421.8M
Quarter-end price (est.)
$24.32

Investors holding NAMS · Q3 2026

InvestorWeightSharesValueChange
RA Capital Management
RA Capital Management, L.P.
2.33%9,550,191$232.3MHOLD
Stanley Druckenmiller
Duquesne Family Office LLC
1.83%3,357,146$81.6MADD+9.3%
Andreas Halvorsen
Viking Global Investors LP
0.18%2,463,911$59.9MREDUCE-41.4%
Lee Ainslie
Maverick Capital Ltd
0.35%1,855,630$45.1MREDUCE-43.2%
Adar1 Capital Management
ADAR1 Capital Management, LLC
0.12%118,623$2.9MHOLD

Options

InvestorTypeUnderlying sharesValueChange
Perceptive AdvisorsPut600,000$14.6MADD+20.0%

Sold out this quarter

InvestorPrior weightPrior sharesPrior valueChange
Ron Baron0.00%9,000$305KEXIT

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026501$421.8M$24.32
Q2 2026610$685.2M$33.89
Q1 2026501$612.3M$32.01
Q4 2025600$661.2M$35.08